Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors

BACKGROUND AND OBJECTIVES: Equilibrative nucleoside transporter (ENT) 1 is a widely-expressed drug transporter, handling nucleoside analogues as well as endogenous nucleosides. ENT1 has been postulated to be inhibited by some marketed tyrosine kinase inhibitors (TKIs). To obtain insights into this p...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur J Drug Metab Pharmacokinet
Asıl Yazarlar: Jouan, Elodie, Moreau, Amélie, Bruyere, Arnaud, Alim, Karima, Denizot, Claire, Parmentier, Yannick, Fardel, Olivier
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer International Publishing 2021
Konular:
Original Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8286641/
https://ncbi.nlm.nih.gov/pubmed/34275128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-021-00703-2
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller